Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

224
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
224
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

149
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
149
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

199
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
199

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A glimpse into the CyberKnife robotic radiosurgery system: technical specifications and developments during thirty years.

Frontiers in oncology·2026
Same author

Vascular-aware mixture-of-experts with a texture-enhanced decoder for accurate X-ray vessel segmentation.

BMC medical imaging·2026
Same author

GSTM3 alleviates FLASH X-ray-induced testicular injury by modulating the ferroptosis pathway.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Study of secondary neutron and γ dose distribution based on a TLD array and 3D-printed tissue-equivalent phantom.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same author

Clinicopathological Characteristics, Prognosis, and Survival of HER2-Low Breast Cancer Patients Based on a Retrospective Cohort Study of 14,642 Patients.

Cancers·2026
Same author

Bibliometric analysis of global research trends in spatially fractionated radiotherapy.

Frontiers in oncology·2026

相关实验视频

Updated: Sep 11, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K

技术说明:基于Topas MC的PBS源模型的独立剂量计算框架.

Xuying Shang1, Yaoying Liu2, Xiaoyun Le3

  • 1School of Physics, Beihang University, Beijing 102206, People's Republic of China; Department of Radiation Oncology, PLA General Hospital, Beijing 100853, People's Republic of China; Hebei Yizhou Tumor Hospital, Hebei, Zhuozhou 072750, People's Republic of China; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, People's Republic of China.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
|August 15, 2025
PubMed
概括

我们开发了一个蒙特卡洛 (MC) 平台用于质子疗法剂量计算,独立于治疗计划系统. 这种多功能框架使准确的剂量验证成为可能,并支持粒子治疗的科学研究.

关键词:
蒙特卡洛 (MC) 框架框架笔光束扫描扫描的使用.质子疗法是一种质子疗法.托帕斯MCMC是最重要的.

更多相关视频

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

相关实验视频

Last Updated: Sep 11, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

科学领域:

  • 医学物理 医学物理
  • 辐射瘤学 辐射瘤学
  • 计算科学 计算科学

背景情况:

  • 蒙特卡洛 (MC) 模拟对于粒子治疗中准确的剂量计算至关重要.
  • 现有的MC平台通常依赖于特定的治疗计划系统 (TPS),限制了它们的多功能性.
  • 开发一个独立的MC平台提高了在研究和临床环境中的灵活性和适用性.

研究的目的:

  • 建立一个独立于治疗计划系统 (TPS) 的多功能蒙特卡洛 (MC) 剂量计算平台.
  • 创建一个全面的方法来构建这样一个质子疗法平台.
  • 为了使准确的剂量验证和支持粒子治疗的科学研究.

主要方法:

  • 在源排放平面中优化相位参数和光束源模型.
  • 为TOPAS MC软件开发了一种自动化方法,将患者计划转换为可执行的MC脚本.
  • 建立了一个源模型参数库,用于可重复的模拟.

主要成果:

  • 在模拟和测量的光束点大小 (<0.3毫米) 之间取得了很好的一致性.
  • 在深度剂量曲线下降率 (<0.1毫米) 和点对点剂量差异 (<0.7%) 中表现出高精度.
  • 实现了100%的3D马通过率,用于分散的布拉格峰和患者计划的高率 (99.96%-100%).

结论:

  • 成功开发了一个全面的MC框架,用于笔束扫描 (PBS) 质子疗法.
  • 该框架使用一个明确定义的光束源模型进行准确的剂量计算.
  • 这种方法促进了剂量验证工具的开发,并推动了粒子治疗的科学研究.